S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NYSE:CLB

Core Laboratories (CLB) Stock Price, News & Analysis

$17.00
+0.50 (+3.03%)
(As of 03/27/2024 ET)
Today's Range
$16.55
$17.03
50-Day Range
$14.11
$17.15
52-Week Range
$13.82
$27.94
Volume
250,749 shs
Average Volume
382,780 shs
Market Capitalization
$796.62 million
P/E Ratio
19.77
Dividend Yield
0.24%
Price Target
$19.88

Core Laboratories MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
16.9% Upside
$19.88 Price Target
Short Interest
Bearish
12.89% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.97mentions of Core Laboratories in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
34.57%
From $0.81 to $1.09 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.33 out of 5 stars

Oils/Energy Sector

153rd out of 242 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

14th out of 19 stocks

CLB stock logo

About Core Laboratories Stock (NYSE:CLB)

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

CLB Stock Price History

CLB Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Q4 2023 Evoke Pharma Inc Earnings Call
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Core Laboratories (CLB) Fell on Mixed Earnings Results
Core Laboratories (CLB) Fell Due to Weak US Land Drilling
CLB Dec 2024 10.000 put
CLB Mar 2024 20.000 put
Q4 2023 Core Laboratories Inc Earnings Call
Here's what to expect from Core Laboratories's earnings
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Ex-Dividend for 3/4 Dividend
2/09/2024
Dividend Payable
3/04/2024
Today
3/27/2024
Next Earnings (Confirmed)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,600
Year Founded
1936

Price Target and Rating

Average Stock Price Target
$19.88
High Stock Price Target
$21.50
Low Stock Price Target
$17.00
Potential Upside/Downside
+16.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$36.67 million
Pretax Margin
8.08%

Debt

Sales & Book Value

Annual Sales
$509.79 million
Cash Flow
$1.05 per share
Book Value
$4.92 per share

Miscellaneous

Free Float
46,508,000
Market Cap
$796.62 million
Optionable
Optionable
Beta
2.39

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Lawrence V. Bruno (Age 63)
    Chairman of the Board, CEO, President & COO
    Comp: $1.53M
  • Mr. Christopher Scott Hill (Age 54)
    Senior VP & CFO
    Comp: $682.02k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 56)
    Senior Vice President of Corporate Development & Investor Relations
    Comp: $564.28k
  • Mr. Mark Damian Tattoli (Age 52)
    Senior VP, Secretary & General Counsel
    Comp: $562.44k
  • Mr. Kevin G. Daniels (Age 60)
    Chief Accounting Officer, Treasurer & VP
  • Mr. Jacobus Schouten (Age 69)
    Managing Director
    Comp: $26.35k
  • J. Donald Dumas Jr.
    Senior VP of Production Enhancement & Business Development

CLB Stock Analysis - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CLB shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price target for 2024?

4 Wall Street research analysts have issued 1-year target prices for Core Laboratories' stock. Their CLB share price targets range from $17.00 to $21.50. On average, they anticipate the company's share price to reach $19.88 in the next twelve months. This suggests a possible upside of 16.9% from the stock's current price.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2024?

Core Laboratories' stock was trading at $17.66 at the beginning of the year. Since then, CLB stock has decreased by 3.7% and is now trading at $17.00.
View the best growth stocks for 2024 here
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CLB earnings forecast
.

How can I listen to Core Laboratories' earnings call?

Core Laboratories will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) announced its earnings results on Wednesday, January, 31st. The oil and gas company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.20 by $0.01. The oil and gas company had revenue of $128.21 million for the quarter, compared to analyst estimates of $127.80 million. Core Laboratories had a trailing twelve-month return on equity of 15.19% and a net margin of 8.03%. During the same period in the prior year, the business posted $0.23 earnings per share.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Wednesday, January 31st. Stockholders of record on Monday, February 12th will be given a dividend of $0.01 per share on Monday, March 4th. This represents a $0.04 annualized dividend and a yield of 0.24%. The ex-dividend date is Friday, February 9th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.24%. The dividend payout ratio is 4.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its first quarter earnings guidance on Wednesday, January, 31st. The company provided earnings per share (EPS) guidance of $0.14-0.18 for the period, compared to the consensus earnings per share estimate of $0.17. The company issued revenue guidance of $122-128 million, compared to the consensus revenue estimate of $126.23 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.48%), Vanguard Group Inc. (11.45%), Boston Trust Walden Corp (4.87%), Congress Asset Management Co. MA (2.91%), Dimensional Fund Advisors LP (2.03%) and Fisher Asset Management LLC (1.61%).
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CLB) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners